Elevance Health Inc.

424.53
-10.51 (-2.42%)
At close: Apr 17, 2025, 3:59 PM
429.73
1.22%
After-hours: Apr 17, 2025, 08:00 PM EDT

Elevance Health Statistics

Share Statistics

Elevance Health has 226.39M shares outstanding. The number of shares has increased by -2.18% in one year.

Shares Outstanding 226.39M
Shares Change (YoY) -2.18%
Shares Change (QoQ) -1.97%
Owned by Institutions (%) 88.37%
Shares Floating 225.94M
Failed to Deliver (FTD) Shares 26
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 2.75M, so 1.21% of the outstanding shares have been sold short.

Short Interest 2.75M
Short % of Shares Out 1.21%
Short % of Float 1.21%
Short Ratio (days to cover) 1.82

Valuation Ratios

The PE ratio is 14.37 and the forward PE ratio is 10.84. Elevance Health's PEG ratio is 6.15.

PE Ratio 14.37
Forward PE 10.84
PS Ratio 0.49
Forward PS 0.4
PB Ratio 2.08
P/FCF Ratio 18.87
PEG Ratio 6.15
Financial Ratio History

Enterprise Valuation

Elevance Health has an Enterprise Value (EV) of 108.85B.

EV / Sales 0.62
EV / EBITDA 11.98
EV / EBIT 18.74
EV / FCF 23.91

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.76.

Current Ratio 2.01
Quick Ratio 2.01
Debt / Equity 0.76
Debt / EBITDA 3.44
Debt / FCF 6.86
Interest Coverage 6.67

Financial Efficiency

Return on Equity is 14.47% and Return on Invested Capital is 6.44%.

Return on Equity 14.47%
Return on Assets 5.12%
Return on Invested Capital 6.44%
Revenue Per Employee $1.7M
Profits Per Employee $57.39K
Employee Count 104,200
Asset Turnover 1.51
Inventory Turnover n/a

Taxes

Income Tax 1.93B
Effective Tax Rate 24.46%

Stock Price Statistics

The stock price has increased by -20.11% in the last 52 weeks. The beta is 0.78, so Elevance Health's price volatility has been higher than the market average.

Beta 0.78
52-Week Price Change -20.11%
50-Day Moving Average 414.38
200-Day Moving Average 450.86
Relative Strength Index (RSI) 47.67
Average Volume (20 Days) 1.72M

Income Statement

In the last 12 months, Elevance Health had revenue of 176.81B and earned 5.98B in profits. Earnings per share was 26.29.

Revenue 176.81B
Gross Profit 157.06B
Operating Income 7.9B
Net Income 5.98B
EBITDA 9.09B
EBIT 9.09B
Earnings Per Share (EPS) 26.29
Full Income Statement

Balance Sheet

The company has 8.29B in cash and 31.23B in debt, giving a net cash position of -22.94B.

Cash & Cash Equivalents 8.29B
Total Debt 31.23B
Net Cash -22.94B
Retained Earnings 33.55B
Total Assets 116.89B
Working Capital 26.36B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.81B and capital expenditures -1.26B, giving a free cash flow of 4.55B.

Operating Cash Flow 5.81B
Capital Expenditures -1.26B
Free Cash Flow 4.55B
FCF Per Share 19.55
Full Cash Flow Statement

Margins

Gross margin is 88.83%, with operating and profit margins of 4.47% and 3.38%.

Gross Margin 88.83%
Operating Margin 4.47%
Pretax Margin 4.47%
Profit Margin 3.38%
EBITDA Margin 5.14%
EBIT Margin 4.47%
FCF Margin 2.57%

Dividends & Yields

ELV pays an annual dividend of $6.6, which amounts to a dividend yield of 1.61%.

Dividend Per Share $6.60
Dividend Yield 1.61%
Dividend Growth (YoY) 4.91%
Payout Ratio 25.7%
Earnings Yield 6.96%
FCF Yield 5.3%
Dividend Details

Analyst Forecast

The average price target for ELV is $511, which is 20.4% higher than the current price. The consensus rating is "Buy".

Price Target $511
Price Target Difference 20.4%
Analyst Consensus Buy
Analyst Count 15
Stock Forecasts

Stock Splits

The last stock split was on Jun 1, 2005. It was a forward split with a ratio of 2:1.

Last Split Date Jun 1, 2005
Split Type forward
Split Ratio 2:1

Scores

Altman Z-Score 3.24
Piotroski F-Score 5